The company's high debt and lack of profitability strain its...
The company's high debt and lack of profitability strain its balance sheet. Negative free cash flow adds risk, but its US$417.4m market cap could potentially allow capital raising to strengthen the balance sheet.
We Think Avid Bioservices (NASDAQ:CDMO) Has A Fair Chunk Of Debt
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3233Followers
0Following
7996Visitors
Follow